首页> 外文期刊>Brazilian Journal of Medical and Biological Research >BC047440 antisense eukaryotic expression vectors inhibited HepG2 cell proliferation and suppressed xenograft tumorigenicity
【24h】

BC047440 antisense eukaryotic expression vectors inhibited HepG2 cell proliferation and suppressed xenograft tumorigenicity

机译:BC047440反义真核表达载体抑制HepG2细胞增殖并抑制异种移植物的致瘤性

获取原文
获取外文期刊封面目录资料

摘要

The biological functions of the BC047440 gene highly expressed by hepatocellular carcinoma (HCC) are unknown. The objective of this study was to reconstruct antisense eukaryotic expression vectors of the gene for inhibiting HepG2 cell proliferation and suppressing their xenograft tumorigenicity. The full-length BC047440 cDNA was cloned from human primary HCC by RT-PCR. BC047440 gene fragments were ligated with pMD18-T simple vectors and subsequent pcDNA3.1(+) plasmids to construct the recombinant antisense eukaryotic vector pcDNA3.1(+)BC047440AS. The endogenous BC047440 mRNA abundance in target gene-transfected, vector-transfected and naive HepG2 cells was semiquantitatively analyzed by RT-PCR and cell proliferation was measured by the MTT assay. Cell cycle distribution and apoptosis were profiled by flow cytometry. The in vivo xenograft experiment was performed on nude mice to examine the effects of antisense vector on tumorigenicity. BC047440 cDNA fragments were reversely inserted into pcDNA3.1(+) plasmids. The antisense vector significantly reduced the endogenous BC047440 mRNA abundance by 41% in HepG2 cells and inhibited their proliferation in vitro (P < 0.01). More cells were arrested by the antisense vector at the G1 phase in an apoptosis-independent manner (P = 0.014). Additionally, transfection with pcDNA3.1(+)BC047440AS significantly reduced the xenograft tumorigenicity in nude mice. As a novel cell cycle regulator associated with HCC, the BC047440 gene was involved in cell proliferation in vitro and xenograft tumorigenicity in vivo through apoptosis-independent mechanisms.
机译:肝细胞癌(HCC)高表达的BC047440基因的生物学功能尚不清楚。这项研究的目的是重建该基因的反义真核表达载体,以抑制HepG2细胞的增殖并抑制其异种移植的致瘤性。通过RT-PCR从人原发性HCC克隆全长BC047440 cDNA。 BC047440基因片段与pMD18-T简单载体和随后的pcDNA3.1(+)质粒连接,以构建重组反义真核载体pcDNA3.1(+)BC047440AS。通过RT-PCR半定量分析了靶基因转染,载体转染的和未加工的HepG2细胞中的内源性BC047440 mRNA丰度,并通过MTT测定法测量了细胞增殖。通过流式细胞仪分析细胞周期分布和凋亡。在裸鼠上进行体内异种移植实验以检查反义载体对致瘤性的影响。 BC047440 cDNA片段反向插入pcDNA3.1(+)质粒。反义载体在HepG2细胞中显着降低了内源性BC047440 mRNA丰度41%,并在体外抑制了它们的增殖(P <0.01)。反义载体将更多细胞以不依赖凋亡的方式阻滞在G1期(P = 0.014)。此外,pcDNA3.1(+)BC047440AS转染显着降低了裸鼠的异种移植瘤致瘤性。作为与HCC相关的新型细胞周期调节剂,BC047440基因通过细胞凋亡独立机制参与体外细胞增殖和体内异种移植的致瘤性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号